Company: LCTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0000950170-25-060090
Chunk: 14

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 14
---
 |                    | 20,000 |
| Audit Committee Member other than Chair                               |     |                    | 10,000 |
| Compensation Committee Chair                                          |     |                    | 15,000 |
| Compensation Committee Member other than Chair                        |     |                    |  7,500 |
| Nominating and Corporate Governance Committee Chair                   |     |                    | 15,000 |
| Nominating and Corporate Governance Committee Member other than Chair |     |                    |  7,500 |
| Financial Strategy Committee Chair                                    |     |                    | 15,000 |
| Financial Strategy Committee Member other than Chair                  |     |                    |  7,500 |

(1) Effective July 1, 2024, the cash fees: (a) for the Chair of the Board decreased from $100,000 to $90,000 and (b) for the Chair of the Finance Strategy Committee decreased from $60,000 to $15,000. Mr. Culley currently serves as Chair of the Finance Strategy Committee and is not receiving any fees for such service. Equity Awards In addition to cash fees, we also grant all non-employee directors an annual stock option to purchase our common shares. During 2024, the annual stock option grant was for 75,000 common shares. All grants are made under the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan. The options vest and become exercisable one year after the grant date subject to the director’s continued service through the vesting date.

<div align='center'>-8-</div>

2024 Non-Employee Director Compensation The following table summarizes certain information concerning the compensation during our fiscal year ended December 31, 2024 to each person who served as a non-employee director during the year and who was not our employee on the date the compensation was earned.

| 2024 Director Compensation Table 
 Name                             |     | Fees Earned 
 or Paid in  
 Cash        |         |     | Option Award(1) |        |     | Total |         |
|:---------------------------------|:----|:------------|--------:|:----|:----------------|-------:|:----|:------|--------:|
| Deborah Andrews                  |     | $           |  77,500 |     | $               | 71,558 |     | $     | 149,058 |
| Dipti Amin                       |     | $           |  57,500 |